Antibody–drug conjugates (ADCs) harness the highly specific targeting capabilities of an
antibody to deliver a cytotoxic payload to specific cell types. They have garnered …

CD24 is a highly glycosylated protein with a small protein core that is linked to the plasma
membrane via a glycosyl‐phosphatidylinositol anchor. CD24 is primarily expressed by …

Cluster of differentiation 24 (CD24) is a small, highly glycosylated cell adhesion protein that
is normally expressed by immune as well as epithelial, neural, and muscle cells. Tumor …

Background Human epithelial cell adhesion molecule (EpCAM) is overexpressed in many
cancers. Anti-EpCAM antibodies have shown promise in preclinical studies, but showed no …

Monoclonal antibodies (mAbs) and their derivatives are currently the fastest growing class of
therapeutics. Even if naked antibodies have proven their value as successful …

Background Terpinen-4-ol, a naturally occurring monoterpene is the main bioactive
component of tea-tree oil and has been shown to have many biological activities. Aim To …

The CD24 protein is a heat-stable protein with a small core that undergoes extensive
glycosylation. It is expressed on the surface of various normal cells, including lymphocytes …

Cancer immunotherapy strategies are based on the utilization of immune checkpoint
inhibitors to instigate an antitumor immune response. The efficacy of immune checkpoint …

CD24 is a highly glycosylated glycophosphatidylinositol (GPI)-anchored protein that is
expressed in many types of differentiating cells and some mature cells of the immune system …

Objective Colon cancer is a great health concern worldwide, as it is the second leading
cause of cancer-related death. Conventional treatment of cancer such as surgery …